| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $59.5M | -21.8% |
| Cost of Revenue | $47.0M | -19.4% |
| Gross Profit | $12.5M | -29.5% |
| R&D Expense | $418K | +574.2% |
| SG&A Expense | $1.9M | +17.7% |
| Operating Income | -$15.6M | +68.9% |
| Pre-tax Income | -$16.1M | +66.7% |
| Income Tax | -$177K | +89.1% |
| Net Income | -$15.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.0M | +38.3% |
| Accounts Receivable | $3.1M | -22.5% |
| Inventory | $5.8M | -32.2% |
| Current Assets | $19.8M | -7.5% |
| Total Assets | $26.2M | +11.0% |
| Current Liabilities | $18.8M | +15.7% |
| Total Liabilities | $21.7M | +26.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.0M | +40.1% |
| Capital Expenditures | $134K | -17.8% |
| Investing Cash Flow | $203K | +186.8% |
| Financing Cash Flow | $6.5M | +106.2% |
| Free Cash Flow | -$5.2M | +39.6% |
| +72.1% |
| EPS (Basic) | -$1.30 | +83.2% |
| EPS (Diluted) | -$1.30 | +83.2% |
| Stockholders' Equity |
| $4.5M |
| -29.6% |